The three-legged stool: Agriculture, oil & gas, and pharmaceuticals

Wait 5 sec.

(Oil & Gas 360) By Greg Barnett, MBA – Politicians, activists, industry groups, and media commentators all love the word subsidy. It is a powerful term because it implies dependence. If an industry receives subsidies, the assumption is that it survives only because taxpayers prop it up.The reality is far more complicated.Agriculture, oil and gas, and pharmaceuticals are three of the most strategically important industries in the United States. They also represent three completely different models of government support. Yet public discussions routinely lump them together under a single label: “subsidized industries.”That characterization may be politically useful, but it is analytically weak.Before comparing these industries, we should define our terms.A tax deduction is not the same thing as a subsidy. A tax deduction allows a business to keep more of its own money. A subsidy typically involves a direct transfer of money or financial support from government to a recipient. Government purchasing is something else entirely. Patent protection and regulatory frameworks represent another category altogether.When these distinctions are ignored, meaningful discussion becomes impossible.Agriculture: The Most Visible Support SystemOf the three industries, agriculture receives the most direct and visible government support.The clearest example is federal crop insurance. According to the U.S. Government Accountability Office, the federal crop insurance program cost approximately $17.3 billion in 2022, including roughly $12 billion in premium subsidies paid on behalf of producers. The remaining costs included payments to private insurers for administering the program and sharing underwriting risk.Those are direct expenditures. No accounting gymnastics are required.Another major program is the Conservation Reserve Program (CRP), under which farmers are compensated for taking environmentally sensitive land out of production. The program has become famous as the government’s willingness to “pay farmers not to plant.” While the policy goals involve conservation, wildlife habitat, erosion control, and water quality, the mechanism is straightforward: taxpayers make direct payments to landowners. Subsidy records indicate CRP payments totaling roughly $27 billion since 2010.Agriculture also benefits from disaster assistance programs, commodity programs, export promotion efforts, and federally supported trade negotiations designed to expand access to overseas markets.None of this suggests farming is over-supported. Food security has always been a matter of national interest. Rather, it demonstrates that agriculture receives substantial government support through direct financial mechanisms that are generally transparent and measurable.Oil and Gas: The Most Misunderstood DebateOil and gas occupies a unique position in the subsidy debate because much of what critics label as subsidies are actually tax provisions.Common examples include deductions for intangible drilling costs, percentage depletion allowances for qualifying producers, and accelerated cost recovery provisions. Critics frequently aggregate these provisions and characterize them as subsidies.Industry participants generally see them differently. They argue that these provisions are mechanisms for recovering investment costs, similar in principle to depreciation provisions available throughout the economy.Reasonable people can disagree over that classification.What is often omitted from public discussion, however, is that oil and gas simultaneously generates enormous streams of government revenue. Federal and state governments collect lease bonuses, royalties, severance taxes, property taxes, permit fees, and various regulatory assessments associated with resource extraction.This creates a fascinating paradox.Agriculture often receives support before a crop is harvested. Oil and gas frequently begins paying governments from the moment production starts.That does not prove one industry is favored over another. It simply demonstrates that the financial relationship between government and industry is far more complex than a one-way subsidy narrative.The public deserves to see both sides of the ledger.Pharmaceuticals: The Hidden Support ModelPharmaceuticals provide perhaps the most interesting example because government support often arrives indirectly.Unlike agriculture, pharmaceutical manufacturers generally do not receive large recurring programs designed simply to support production. Instead, the government helps create the ecosystem within which those companies operate.The National Institutes of Health provides more than $40 billion annually in biomedical research funding, supporting foundational scientific discoveries that often become the basis for future commercial therapies. While pharmaceutical companies do not receive all of this funding directly, many breakthrough medicines can trace their origins to government-funded research. NIH support therefore functions as a powerful innovation accelerator.The second pillar is government purchasing.Through Medicare, Medicaid, the Veterans Health Administration, the Department of Defense, and other federal programs, the government represents one of the largest purchasers of pharmaceuticals in the world. The federal government is not necessarily subsidizing production in the traditional sense. Instead, it serves as a massive and highly reliable customer.The third pillar is intellectual property protection.Patent protection is not a subsidy. However, government-enforced exclusivity grants innovators a temporary legal monopoly that can be extraordinarily valuable. The system exists because policymakers believe the prospect of future profits encourages investment in research and development.Whether one supports or opposes the structure, its economic significance cannot be overstated.The Tax Burden Nobody Talks AboutOne of the least discussed aspects of this debate involves land taxation.In many jurisdictions, agricultural land receives favorable assessment treatment based on agricultural use rather than market value. The rationale is straightforward: preserving farmland serves the public interest.Meanwhile, producing mineral properties, pipelines, processing facilities, and extraction infrastructure are often subject to severance taxes, property taxes, production taxes, and extensive regulatory fee structures.Again, neither system is inherently right or wrong.The point is that government support and government burden can coexist within the same industry. Simplistic subsidy rankings rarely capture that reality.The Three-Legged StoolThe more compelling question is not which industry receives the most assistance.The more compelling question is why all three receive assistance.Agriculture provides food.Oil and gas provides energy.Pharmaceuticals provide health.Remove any one of those pillars and the other two immediately suffer.Modern agriculture depends on diesel fuel, natural gas-based fertilizers, petrochemicals, machinery lubricants, and transportation networks. Pharmaceutical manufacturing depends on energy, petrochemical feedstocks, plastics, packaging, refrigeration, and logistics infrastructure. Oil and gas companies depend on healthy workers, medical systems, food production, and functioning communities.These sectors are not competitors.They are co-dependent.That is why the center of the Venn diagram is not agriculture, energy, or medicine.The center is modern civilization.Follow the Dollars, Not the PoliticsAmerica does not support agriculture because farmers are nice people.America supports agriculture because hungry nations become unstable nations.America does not support pharmaceutical research because drug companies need help.America supports pharmaceutical innovation because pandemics, disease, military readiness, and public health are national security concerns.America does not maintain energy policy because oil companies need friends in Washington.America does so because modern civilization runs on energy.The deeper truth is that these aren’t merely industries.They are strategic infrastructure. Food. Energy. Health.A nation that cannot produce those domestically is a nation that becomes dependent on others for survival.The subsidy debate often generates more emotion than understanding because people use one word to describe fundamentally different things.Agriculture receives substantial direct payments and insurance support.Pharmaceuticals benefit from government-funded research, patent protections, and enormous public purchasing programs.Oil and gas benefits largely through tax treatment while simultaneously providing governments with substantial revenues through royalties, lease payments, and production-related taxes.These distinctions matter.Critics often describe support for agriculture, pharmaceuticals, or energy as corporate welfare. Yet every nation on Earth actively protects its food supply, energy supply, and healthcare capacity. The debate is not whether America should support these sectors. The debate is how much support is appropriate before strategic resilience becomes economic distortion.”The China TestOne useful thought experiment: here’s a simple question.Would Americans be comfortable importing: 90% of their food? 90% of their fuel? 90% of their medicines? Most people answer “absolutely not.”Once you answer that question, you’ve already accepted the principle of strategic national policy. A nation can survive high taxes. A nation can survive budget deficits. A nation can survive political dysfunction. But history shows nations struggle to survive prolonged shortages of food, energy, or medicine. That is why governments, regardless of political party, inevitably support all three. Not because the industries are special. Because the functions are indispensable.Ask the Right QuestionPerhaps the wrong question is whether these industries receive government support.Every advanced nation on Earth supports domestic food production, energy production, and healthcare capacity in one form or another. The mechanisms vary. The objectives do not.Agriculture, oil and gas, and pharmaceuticals are not simply industries. They are the systems that provide food security, energy security, and health security. Governments support them not because they are politically connected, but because the consequences of failure extend far beyond quarterly earnings reports.The numbers tell us that each sector benefits from a different mix of direct payments, tax preferences, research investment, government purchasing, regulatory structures, and trade policy. Those distinctions matter and should be debated honestly. But focusing exclusively on the word subsidy risks missing the larger point.A nation that cannot feed itself, power itself, or care for itself eventually discovers that dependence is far more expensive than preparedness.The real measure of success is not how much support these industries receive. The real measure is whether those policies create resilience, innovation, affordability, and security for the American people. The three-legged stool does not stand because one leg is more important than the others. It stands because all three work together.Food. Energy. Health.Remove one, and the stool wobbles.Remove two, and it falls.The overlap at the center of the Venn diagram is not agriculture, oil and gas, or pharmaceuticals. The overlap is modern civilization itself.And that may be the most important distinction of all. The debate should not begin with who gets support. It should begin with what America cannot afford to lose.Until Americans learn to separate those categories, discussions about subsidies will continue to generate far more heat than light. And as with any serious analysis, the numbers matter. Without them, the argument is just an ice cube without water.By oilandgas360.com contributor Greg Barnett, MBA.The views expressed in this article are solely those of the author and do not necessarily reflect the opinions of Oil & Gas 360. Please consult with a professional before making any decisions based on the information provided here. Please conduct your own research before making any investment decisions.